Mingchen Health released its 2022 annual report, the company’s operating revenue reached 945 million yuan ($136.63 million), with an increase of 27.05% compared to the same period last year. The net profit of the company was ¥25.32 million ($3.66 million), a decrease of 81.03% compared to 2021. Mingchen Health Co.,Ltd (Mingchen Health), China's famous Shampoo Producer, released its 2022 annual report, the company’s operating revenue reached 945 million yuan ($136.63 million), with an increase of 27.05% compared to the same period last year. The net profit of the company was 25.32 million yuan ($3.66 million), a decrease of 81.03% compared to 2021. In March of last year, Mingchen Health was involved in insider trading during its acquisition of Hainan Huaduo and Hangzhou Leiyan companies. Three individuals were fined a total of 79 million yuan ($11.42 million). At the end of 2022, the company decided to terminate the acquisition of equity in Kashgar Aosu Network Technology Co., Ltd. Public information shows that Mingchen Health is a high-tech enterprise engaged in the research and development, production, and sale of health care products. Its main products include beauty, hair care, and daily cleaning products, under brands such as "DIFASO," "Meiwon," and "Eihsia." In August 2020, the company expanded into the gaming industry through external mergers and acquisitions. In terms of its main daily chemical business, the company will continue to optimize its traditional distribution channels, strengthen distribution, and promote the construction of end-point retail outlets. The company will leverage its advantageous position in traditional distribution channels and strengthen channel distribution and retail terminal store construction on a dealer-by-dealer basis, focusing on key retail outlets to drive urban sales comprehensively. The focus of promoting the transformation of terminal channels will be on profit-oriented products, with efforts to improve terminal product profits and maintain and strengthen existing stores while adding advantageous network stores. Mingchen Health said the company's business goals for 2023 are to achieve operating revenue of 1.6-1.9 billion yuan ($231.2 million-274.6 million) and net profit of 120-150 million yuan ($17.34-21.68 million). Following the overall budget plan above, the company will strive to achieve further growth in operating revenue and net profit. In addition, Mingchen Health has released its 2023 Q1 report, which shows that the company achieved a total operating revenue of 407 million yuan ($58.82 million), with a remarkable increase of 172.98%. The net profit reached 34.1 million yuan ($4.93 million).

German flavour and fragrance producer Symrise reported sales growth of 12.8 % to €1230.2 million ($1359.94 million) in reporting currency in the 2023 Q1. Symrise said the growth in Q1 was partly due to high demand for cosmetic ingredients. German flavour and fragrance producer Symrise reported sales growth of 12.8 % to €1230.2 million ($1359.94 million) in reporting currency in the 2023 Q1. Symrise said the company made a successful start to the year due to sustained high demand and a diverse business portfolio. The growth was driven by both Scent & Care and Taste, Nutrition & Health segment. Scent & Care, which deals with fragrances, aroma molecules, and cosmetic ingredients, saw a sales increase of 8.3% to €454.0 million ($501.88 million) in the first quarter compared to 2022 Q1. Organic sales growth was at 4.2%. The Fragrance division had strong growth, particularly in the luxury segment. Fine Fragrances performed exceptionally well, with high double-digit growth compared to the previous year's first quarter. Consumer Fragrances also saw single-digit growth, driven by demand for hygiene and cleaning products. However, the Aroma Molecules division faced challenges in a difficult market environment, resulting in declining sales due to increased competition from Asia and high customer inventories leading to lower sales volumes. Demand for menthols and terpenes products also declined compared to the previous year. On the other hand, the Cosmetic Ingredients division continued to grow strongly, with double-digit organic growth in the first quarter. The growth was mainly driven by the EAME regions and Latin America, particularly in the application areas of active cosmetic ingredients. Symrise's Taste, Nutrition & Health segment, which focuses on taste solutions for food and beverages, pet food, and nutrition, experienced a sales increase of 15.6% to €776.1 million ($857.95 million) in the first quarter. Organic growth was at 14.6%, and all regions contributed to this positive result. The Latin America and EAME regions were particularly strong growth drivers. Dr. Heinz-Jürgen Bertram, CEO of Symrise AG: “Symrise was able to seamlessly continue last year's positive business development at the beginning of this year. Despite high inflation and continued volatility in our markets, we are optimistic about the rest of the year and expect robust demand. Our diversified portfolio and our broad international positioning will also help us realize our growth potential and create lasting value this year. We therefore also confirm our outlook. For the current fiscal year, we are aiming for organic sales growth of 5 % to 7 % and an EBITDA margin of around 20 %." Source: Symrise

On April 26th, the Shanghai Medical products Administration issued the first "on-site personalized service" cosmetics production license to Shanghai L’Oréal International Trading Co., Ltd. With the gradual improvement of relevant regulations, customized cosmetics expect to see booming development in China. On April 26th, the Shanghai Medical products Administration issued the first "on-site personalized service" cosmetics production license to Shanghai L’Oréal International Trading Co., Ltd.'s SkinCeuticals store located in the Shanghai International Finance Center. After obtaining the license, the company can engage in personalized services that involve direct contact with cosmetics at the operating site. The "on-site personalized service" provided by the above-mentioned store is called the SkinCeuticals CUSTOM DOSE personalized skincare service, which is divided into four steps: professional recommendation, accurate measurement, homogeneous mixing, and personalized packaging. According to media reports, the service relies on a mini cosmetics production table for personalized skincare. The core of the service is a formulation device that combines laboratory formulation with factory production mode. The device contains eight different pre-formulated device that can be added and mixed on-site, and the combination of formulations can reach dozens of varieties. This "on-site personalized service" was first exhibited in China at the second China International Import Expo in 2019. According to a store employee, "when customers enter the store, we will first help them do a skin test to see the condition of their skin. Then an iPad will provide a related questionnaire, and the customer needs to answer it based on their personal skin condition. Finally, the (system) will recommend the suitable combination of essence ingredients, or customers can directly choose the combination they want." In November 2022, the Medical products Administration issued the NMPA’s Announcement on Carrying out the Pilot Project of Cosmetics Personalized Services, officially opening the door to customized cosmetics. The notice stated that a one-year pilot project for personalized cosmetic services will be launched in five provinces and cities, including Beijing, Shanghai, Zhejiang, Shandong, and Guangdong. The pilot will encourage companies to conduct trials in skin testing, product tracking, and personalized skincare service programs for ordinary cosmetics such as makeup and skincare. According to the "Trend Insight Report on Customized Cosmetics" released by Qingyan Intelligence, the global personalized beauty market grew from $29.25 billion in 2021 to $37.72 billion in 2022, with a compound annual growth rate of 11.87%. It is expected to exceed 500 billion yuan ($72.29 billion) by 2028. With the development of relevant regulations, combined with the huge potential of the customization market, major companies have showcased their exclusive customized cosmetics services at the fifth China International Import Expo held in Shanghai last November to seize the market opportunities. For example, Shiseido's high-end beauty personalized customization brand, IPSA, debuted the concept of customized beauty at the expo. According to the IPSA brand leader, the personalized customization project "Skin Couture Station" is planned to land in Pudong, Shanghai this year and will be based on the newly launched high-energy black crystal cream, adapting to the individual skin conditions of each customer. Similarly, Amorepacific also exhibited its own customized black technology at the expo. Its personalized bath salt service (Mind-linked Bathbot) is based on emotional analysis of brain waves and offers customized therapeutic "bath bombs". In addition, COSMAX, a global OEM giant from Korea, has made customized product services a key project for deepening this year, and recently announced the launch of the customized cosmetics platform "3WAAU," which provides precise recommendations among 12.6 million formula combinations through one-to-one targeted questionnaires. Domestic brands have also focused on personalized customization. In August last year, SYoung Group's latest intelligent manufacturing base also focused on personalized customization. It is understood that SYoung Group relies on the analysis of over 60 million users' skin data to segment 1,620 skin types for East Asian faces, and matches and verifies 1,620 formulas from the perspectives of efficacy and skin feel. With the gradual improvement of relevant regulations, the continuous investment of major beauty brands, and more customized cosmetics landing in the market, the personalized cosmetics market may be on the right track and expect to see booming development in China.

Yatsen, the Chinese cosmetics producer, released its 2022 annual report. The company’s revenue reached 3.71 billion yuan ($535 million) in 2022, down 36.54% compared to 2021. Yatsen reported 821 million yuan ($118.53 million) net loss in 2022, which reduced by 725.7 million yuan ($104.73 million) compared to 2021. Yatsen, the Chinese cosmetics producer, released its 2022 annual report. The company’s revenue reached 3.71 billion yuan ($535 million) in 2022, down 36.54% compared to 2021. Yatsen reported 821 million yuan ($118.53 million) net loss in 2022, which reduced by 725.7 million yuan ($104.73 million) compared to 2021. Yatsen reported net loss for three consecutive years. Yatsen Holding Ltd is a China-based holding company engaged in production and sales of cosmetics and skincare products. The Company have introduced and purchased several brands in the color cosmetics and skincare industry, such as Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (for its China-based operations), Eve Lom, Pink Bear, and EANTiM. The company’s main brand, Perfect Diary, is one of the top-selling color cosmetics brands in China. Yatsen mainly interacts with customers directly through both online and offline channels, and has a wide reach across major e-commerce, social media, and content platforms in China. During the period, the skincare business grew strongly and the revenue structure continued to improve. The annual revenue of the skincare business reached RMB 1.24 billion ($180 million) in 2022, a year-on-year increase of 45.2%, accounting for 33.5% of the total revenue. The net income of its three major mid-to-high-end skincare brands increased by 99% year-on-year in 2022. In addition, the revenue of Color Cosmetics Brands reached 2.42 billion ($350 million), down 50.39% compared to 2021. Meanwhile, Yatsen continued to optimize its cost structure. The financial report showed that its market and sales expense ratio decreased by 5.7 percentage points year-on-year to 62.9% in 2022. Against the backdrop of the overall pressure faced by the cosmetics industry last year, Yatsen continued to promote its strategic transformation, steadily advancing towards high-quality development while shifting its focus to "reducing fat and increasing muscle." In addition, Yatsen has been increasing its investment in research and development to ensure continuous product innovation. The financial report showed that the company's total R&D investment reached 130 million yuan ($18.77 million) in 2022, with R&D expense ratio continuously increasing from 2.4% in 2021 to 3.4% in 2022, maintaining a leading position among global peers. As of December 31, 2022, Yatsen had applied for 174 patents worldwide, including 43 invention patents (some of which are in the process of being transferred).

After completing a successful financial performance in 2022, Beiersdorf delivered a strong start to the 2023 financial year, with organic sales in the first quarter reaching €2,481 million ($2,740 million), which represents a 12.2% increase from the previous year. After completing a successful financial performance in 2022. Beiersdorf delivered a positive start to the 2023 financial year, with sales in the first quarter reaching €2,481 million ($2,740 million), which represents a 12.2% increase from the previous year. In terms of the business segment, the Consumer Business Segment of Beiersdorf earned €2.1 billion ($2.32 billion) in sales and experienced significant organic sales growth of 14.8%. The Derma business, which includes the Eucerin and Aquaphor brands, had a remarkable performance, and NIVEA had an exceptional first quarter, especially in Europe and Emerging Markets. The tesa Business Segment achieved 0.9% organic growth year-on-year, with sales of €424 million ($468.31 million) in the first quarter. In terms of the main brands, In the first quarter, the core brand of the Beiersdorf, NIVEA experienced impressive organic growth of 18% year-on-year, primarily driven by the growth of sun care, lip care, deodorants, and face care categories. The growth was supported by price increases and a positive volume contribution across the entire product portfolio. NIVEA achieved double-digit growth in all major markets. The Derma brands, Eucerin and Aquaphor, also showed remarkable performance, with organic sales growth of 26.9%. The US market continued to show strong demand for these brands, particularly in the sun care category. Beiersdorf's luxury brand, La Prairie, experienced a 12% decline in sales during the first quarter. This was primarily due to challenging market conditions in China, resulting from changes in Covid policies, which had a significant impact on the brand's strong travel retail business. However, retail sales in China have shown significant recovery since February, starting with brick-and-mortar retail and, more recently, in travel retail as well. Vincent Warnery, the CEO of Beiersdorf said: “Beiersdorf had an excellent first quarter. Our efforts to transform NIVEA are clearly paying off: Our brand icon grew in all regions and March was actually the best month in the history of the brand. With strong, double-digit sales growth, NIVEA in Europe and in the Emerging Markets, along with our successful Derma business, compensated for a difficult quarter at La Prairie – one that was negatively impacted by the effects of the Corona lockdown in China.” Vincent Warnery added: “That clearly shows that we’re like a four-wheel drive vehicle: If one wheel loses traction, the others will keep the vehicle moving forward. That gives us even greater stability and security in times shaped by volatility and crises.” Beiersdorf said the company expects the Group's organic sales growth to be in the mid-to-high single digit range. The company also expects that the Group's EBIT margin (excluding special factors) will slightly exceed the previous year's level. Source: Beiersdorf

After a successful financial performance in 2022, Beiersdorf delivered a successful start in financial year 2023 with sales increased by 12.2% to €2,482 million ($2710 million) in Q1. Beiersdorf, the German skin care giant, announced that after completing “one of its most successful financial years in recent history, defying the volatile market environment of 2022”, the company delivered a remarkable start in financial 2023. The organic Group sales of Beiersdorf increased by 12.2% to €2,482 million ($ 2710 million) in Q1, which is above the current capital market expectation. In terms of the segments, organic sales in the Consumer business segment increased by 14.8% to €2,057 million ($2246.2 million), while tesa business segment delivered 0.9% organic sales growth to €425 million ($464.09 million). “Our strategy is working – we are extremely well-positioned. In the first quarter, in addition to the NIVEA business in Europe, our main growth and profitability drivers include the NIVEA business in Emerging Markets and our successful Derma business. This makes us more stable and able to withstand crises. We are therefore better able to compensate for volatility in individual areas.” Vincent Warnery, the CEO of Beiersdorf said. With a remarkable performance in Q1, Beiersdorf now expects a mid- to high-single-digit range organic sales growth from mid-single-digit range for both the Group and the Consumer Business Segment in fiscal year 2023. Beiersdorf said the Q1 statement will be released on April 26, 2023. In the financial year of 2022, Beiersdorf delivered a double-digit growth in group sales, which Beiersdorf regarded it as the “best performance in recent decades”. In 2022, the group sales of Beiersdorf rose to €8.8 billion ($9.6 billion) with an increased of 10.2% in organic terms. The Consumer Business Segment recorded an outstanding, double-digit rise in organic sales of 10.5%. Beiersdorf said tha all regions and brands contributed to the growth in the Consumer Business Segment. Beiersdorf gained market share on every continent led by the NIVEA brand and the Derma business. The regions Africa/Asia/Australia and Americas achieved 10.2% and 23.2% organic sales growth respectively, double-digit growth two years in a row. Additionally, Europe also delivered good sales growth of 5.0% in Europe despite the ongoing war in Eastern Europe. The core brand NIVEA grew organically by 9.6% year on year in 2022. Both parts of the business, Skin Care and Personal Care, saw substantial growth. Beiersdorf’s luxury brand La Prairie increased its organic sales by 1.9%. Nominal sales were up from €599 ($654.09 million) to €655 million ($715.24 million).

CHAILEEDO noticed that three Chinese beauty companies focusing on functional skincare made the list of the top 100 global beauty companies released by WWD. WWD recently released the list of the top 100 global beauty companies, of which 10 Chinese companies made the list, three more than last year. What's new for Chinese beauty companies in 2022, amidst the changing environment and the turbulent international political and economic situation? Which cosmetics sell best? Three new Chinese companies are on the list According to the Top 100 list revealed by WWD this year, the Chinese companies on the list, in order of ranking, are PROYA COSMETICS CO. LTD.(hereinafter referred to as PROYA), Bloomage Biotech, Shanghai Jahwa, S’Young, Yunnan BOTANEE Biotechnology Group Co., Ltd.(hereinafter referred to as BOTANEE), JALA, YATSEN, CHICMAX, JOY Group and Marubi. The highest-ranked company, PROYA, came in at No. 40 with 2022 sales of 5.9 billion yuan ($878.1 million), with brands such as PROYA, Uzero, Anya, Yoya, Cats &Roses, Timage, Ins Baha, Off&Relax. Bloomage Biotech followed it and ranked 47th in the WWD Top 100, with revenues of 5.08 billion yuan ($756.1 million), 0.82 billion yuan ($122 million) lower than PROYA. Shanghai Jahwa 2022, in third place, had sales of 5.08 billion yuan ($756.1 million), ranking 48th in the WWD Top100. The remaining companies are YATSEN (No.62), Chicmax (No.71), Joy Group (No.86) and Marubi (No.97). Through The 2022 Beauty Top 100 from WWD in 2022 and 2021, CHIALEEDO found that 10 Chinese companies made the list this year, compared to seven last year. The new entrants this year are S’Young, BOTANEE and JOY Group. In addition to the new entrants, the ranking of companies originally on the list has also changed significantly. PROYA improved from 49th place last year to 40th this year. Bloomage Biotech rose from 65th place to 47th this year. Several other beauty companies showed a downward trend, with Shanghai Jahwa dropping from 43rd to 48th, YATSEN falling from 39th to 62nd, JOLA dropping from 51st to 57th, CHICMAX from 58th to 71st and Marubi from 91st to 97th. (Source: The 2022 Beauty Top 100 from WWD) Significant gains for functional skincare companies Of the 10 companies on this year's list, eight are skincare-based, with three of them - PROYA, Bloomage Biotech and BOTANEE - focusing on functional skincare. CHAILEEDO notes that all three Chinese companies have exceeded 5 billion yuan ($722.3 million) in revenue this year. PROYA COSMETICS CO. LTD.(hereinafter referred to as PROYA), a leading Chinese brand focusing on skincare products, cannot grow without its a-hero-product strategy. For example, it launched PROYA Deep Ocean Energy and PROYA Double Effect Brightening Essence in 2020. The two products promoted PROYA to upgrade its brand under the wind of efficacy skincare, according to public information. During the Chinese Double 11 Shopping Festival in 2022, PROYA Deep Ocean Energy and PROYA Double Effect Brightening Essence sales across the internet exceeded 200 million yuan ($28.9 million). Recently, PROYA officially announced its 2022 financial data with a record high performance. Its annual revenue achieved 6.385 billion yuan ($922.4 million), up 37.82% year-on-year. Its net profit attributable to the parent company was 817 million yuan ($118 million), up 41.88% year-on-year. The financial report showed that its single brand PROYA’s annual revenue was 5.264 billion yuan ($760.4 million), accounting for 82.74% of total revenue, making PROYA the number one Chinese local beauty brand. (Credit: PROYA Deep Ocean Energy and PROYA Double Effect Brightening Essence ) Another company mentioned above, Bloomage Biotech, is also a leader in China's functional skincare sector. According to public information, Bloomage Biotech was established in 2000. In 2007, the company became the world's largest producer of hyaluronic acid. Its brands are mostly functional skincare brands, including BIOHYALUX, QUADHA, MEDREPAIR and Bio-MESO etc. From the data of the last 5 years, Bloomage Biotech's functional skincare business has grown rapidly from 290 million yuan ($41.9 million) to 4.607 billion yuan ($665.5 million) in just 5 years with a growth rate of over 100% for four consecutive years from 2018 to 2021. It showed a slowdown in 2022 but also achieved a high growth rate of 46.07%. It can be said that after five years of development, Bloomage Biotech has transformed from a traditional hyaluronic acid raw material enterprise into a full industry chain enterprise covering raw materials, medical end products and functional skin care products. (Credit: QUADHA Single Essence at Bloomage Biotech ) Moreover, the strength of BOTANEE, a new company on the list this year, should not be underestimated. Founded in 2010, BOTANEE is a large health industry group integrating R&D, production and marketing, and is positioned as skin health and internet+. In addition to the core brand Winona, BOTANEE also has WINONA Baby, Beauty Answers, Zirun, Doudoukang and other brands. Recently, BOTANEE released its 2022 results report. The report shows that it achieved revenue of 5.014 billion yuan ($724.3 million) in 2022, up 24.65% year-on-year. Its main brand, Winona, which focuses on sensitive skin care, has contributed more than 97% of BOTANEE's revenue for many years. According to statistics from Euromonitor, a consumer market research firm, Winona ranked eighth in the skincare market during the reporting period, climbing two places from FY 2021. Its market share in the Chinese dermatology-grade skincare sector rose to 23.2%. During last year's Chinese Double 11 Shopping Festival, Winona was ranked 6th in the beauty category on Tmall and was the only Chinese brand to be listed in the Top 10 in the beauty and skincare category on the Chinese Double 11 Shopping Festival for five consecutive years. (Credit: Winona Sunscreen Cream at BOTANEE) China's functional skincare market is becoming more segmented According to CHAILEEDO Data, the functional skincare market achieved from 19.6 billion yuan ($2.8 billion) to 30.8 billion yuan ($4.4 billion) during 2019-2021. It is estimated that it will exceed 41.1 billion yuan ($5.9 billion) and 55.5 billion yuan ($8 billion) in 2022 and 2023. At the same time, the sector of functional skincare is becoming more and more segmented. As Bloomage Biotech pointed out in its annual report, "At present, skincare consumption is becoming increasingly mature. Consumers’ demands upgraded from basic skincare to professional skincare with stronger functional attributes. Then consumers pursue aesthetic medicine. With escalating and irreversible demand, the market started to show the development trend of segmentation." The diversified demand has led to a more segmented Chinese skincare market, which has led to the emergence of category concepts such as functional skincare, dermatological-grade skincare, sensitive skin care and consumer concepts such as ingredient parties. Chinese skincare-focused cosmetic companies have taken note of this trend of segmentation in China's functional skincare market and have invested in the sectors in which they excel. For example, Bloomage Biotech, which focuses on hyaluronic acid skincare, has launched four functional skincare brands in different sectors. According to the information released by Bloomage Biotech, BIOHYALUX focuses on hyaluronic acid technology repair. QUADHA is precision skincare hardcore anti-aging. Bio-MESO is an oil skin skincare brand. MEDREPAIR focuses on the sensitive skin. CHAILEEDO found that this year, a number of Chinese brands have upgraded their hero single product for the niche sectors of functional skincare. For example, Dr. Alva's Probiotic Mask (4x Centella Asiatica Extract + Genesis Rui Jing Yan ingredients), Arden Orange Eye Cream (with the star anti-oxidant ingredient Idebenone as the core to reduce free radicals, fight oxidation and synergise with 5 major anti-oxidant and anti-ageing ingredients) and Spring Letter Vitamin C Essence (using two ingredients, Tromantol and De-Lightening Muscle Belly, to form an anti-oxidant matrix) are all aces or staples of their brands. PROYA has recently launched a 3.0 upgrade for its ace big-ticket product PROYA Double Effect Brightening Essence, claiming to use the exclusive ingredient Nox-Age® and upgrading ergothioneine to the high-purity ergothioneine Max for purer ingredients and gentler results. And L'Oréal continues to work on Pro-Xylane, using a 20% concentration of hyoscyamine pro in its eye creams to achieve a more efficient anti-ageing effect with a higher concentration of the ingredient. This trend is a reflection of Chinese consumers' growing demand for more precise skincare. As Angie MA, Vice President of L’Oréal China and General Manager of L’Oréal China Dermatological Beauty Division said, "The whole market trend is actually due to consumers' self-advancement. The sector will be booming because consumers know more and more and are more knowledgeable."

Green Pine, the Chinese cosmetics ODM delivered 2.92 billion yuan ($421.32 million) in operating revenue in 2022, down 21.01% compared to 2021. While the company reported net loss of 742 million ($107 million). FuJian Green Pine Co.,Ltd (Green Pine), the Chinese cosmetics ODM delivered 2.92 billion yuan ($421.32 million) in operating revenue in 2022, down 21.01% compared to 2021. While the company reported net loss of 742 million ($107 million). Green Pine was established in 2001 and was listed on Shenzhen Stock Exchange in October 2010. The company is an cosmetics ODM company, primally engaged in the research and development, design, and manufacturing of cosmetics, with business operations covering areas such as facial masks, skincare products, wipes, nonwoven fabrics, and functional chemicals. Green Pine’s cosmetics and related businesses are mainly operated by the company’s wholly-owned subsidiary NOX BELLCOW COSMETICS CO., LTD. During the reporting period, NOX BELLCOW achieved operating revenue of 2.08 billion yuan ($300 million), with a decrease of 17.17%. NOX BELLCOW’s reported net loss of 275.96 million yuan ($39.85 million). Green Pine stated that the decline in the company's performance was mainly affected by macroeconomic and industry environment factors, with suppressed demand for facial masks and skincare products, and a shift from high growth to negative growth in the cosmetics retail market. During the reporting period, demand for wipes products in overseas markets weakened, and high shipping prices led to a significant decline in export orders for wipes. In addition, some wipes production for overseas customers was temporarily delayed and revenue was not confirmed. Meanwhile, due to factors such as rising commodity prices and supply chain shortages, the procurement costs of some key materials continued to increase, resulting in an increase in raw material costs compared to the same period last year, leading to an overall decline in gross profit margin due to a rise in unit costs.

BTN, the parent company of China famous skin care brand Winona posted 863.3 million yuan ($124.7 Million) in operating revenue in 2023 Q1, with an increase of 6.78% compared to the same period of 2022. Yunnan Botanee Bio-Technology Group Co. LTD (BTN), the parent company of China famous skin care brand Winona posted 863.3 million yuan ($124.7 Million) in operating revenue in 2023 Q1, with an increase of 6.78% compared to the same period of 2022. The company’s net profit in Q1 reached 158.27 million yuan ($22.85 Million), saw growth of 8.41%. BTN, with the core brand "Winona" and multiple brands in parallel development, focuses on providing gentle and professional skincare products that use pure natural plant active ingredients. They particularly cater to sensitive skin and are a professional cosmetics manufacturer that deeply integrates with the internet in terms of product sales channels. The company strives to provide consumers with professional cosmetics that meet the diverse needs of different skin types. The company’s brands include include Winona, Winona Baby, AOXMED. BTN main products include skincare products such as creams, toners, masks, essences, and lotions, as well as makeup products such as sunscreens, BB creams, and makeup removers. In addition to skincare and makeup. The company is also involved in the research and development, production, and sales of skin care-related medical equipment products. These mainly include medical equipment products such as hyaluronic acid repair biofilm and hyaluronic acid repair dressings that are professionally used to protect and care for postoperative barrier-damaged skin in minimally invasive surgery. In 2022, BTN 's operating revenue in 2022 increased by 24.65% compared to 2021, reaching 5.014 billion yuan ($728.7 million). Its net profit also grew by 21.82% to 1.051 billion yuan ($152.7 million). The 2022 annual report has disclosed the sales data of BTN 's product lines both online and offline. In terms of online product sales, the company's sales revenue reached 2.172 billion yuan ($313.64 million) in 2020, and surpassed 4 billion yuan ($577.6 million) in 2022, reaching 4.228 billion yuan ($610.5 million). Sales of offline products have also grown steadily, with offline product sales reaching 449 million yuan ($64.84 million) in 2020 and 970 million yuan ($140 million) in 2022. In addtion, BTN 's "Central Factory New Base Construction Project" has been completed and put into operation. With the new central factory, the company's annual output value can reach 5 billion yuan ($722 million). The completion of the central factory not only signifies a significant step forward for Betaine in terms of improving production efficiency, reducing production costs, and increasing its own production capacity, but also leads to higher levels of process control, quality supervision, process improvement, and enhanced quality control.

Henkel, the Düsseldorf-based consumer goods group, have formed a collaboration with SAP to promote digital co-innovation by utilizing a distinctive blend of future-ready software, technology, and ecosystem. The strategic partnership aims to accelerate Henkel's digital transformation efforts. Henkel, the Düsseldorf-based consumer goods group, have formed a collaboration with SAP to promote digital co-innovation by utilizing a distinctive blend of future-ready software, technology, and ecosystem. The partnership aims to accelerate Henkel's digital transformation efforts. A customized approach will be taken to implement two major changes: the adoption of the advanced software SAP S/4HANA and a complete transition to the cloud. This move will enable Henkel to take a leap forward by accessing the latest digital innovations in a significantly faster manner, while also reaping the benefits of the new ecosystem, technologies, and software capabilities. The partnership will result in increased data-driven decision-making in real-time and faster time-to-market through more efficient and sustainable processes, benefiting Henkel across its entire value chain. “Digital transformation, alongside innovation and sustainability, is one of the key levers of our purposeful growth agenda to achieve competitive edge. To drive digital across all our business activities, we need strong collaborations like these – to co-innovate and pool expertise. That’s why I am happy to see that our long-lasting partnership with SAP evolves to the next level of digital innovation,” says Carsten Knobel, CEO of Henkel. “Our decision to strengthen our partnership reflects our commitment to innovation and our willingness to embrace change to further improve our business,” Carsten Knobel added. Henkel and SAP have had a longstanding partnership spanning several decades, which extends beyond the mere acquisition of software and technologies. The collaboration has involved working together on innovations and developing customized solutions that cater to Henkel's specific business needs and challenges, with the aim of driving digitalization and making it a key driver of value. With the strengthened partnership, the two companies are taking a significant step forward to accelerate innovation and advance to the next level. “By digitalizing and automating their core processes, organizations gain the agility and speed they need to respond to rapid change,” says Christian Klein, CEO and Member of the Executive Board of SAP SE. “We’re excited to extend our longstanding partnership with Henkel to accelerate their digital transformation to the cloud and help future proof their business,” adds Christian Klein. Source: Henkel

Zanyu Tech, the surfactants and oleochemicals manufacturer and household cleaning products OEM, reported 69.87 million yuan ($10.09 Million) net loss in 2022. Zanyu Technology Group Co., Ltd (Zanyu Tech), the surfactants and oleochemicals manufacturer and household cleaning products OEM released its 2022 annual report on 26th Apr. The company delivered operating revenue 11.24 billion yuan ($ 1.62 billion), with an increase of 0.3%. While the company reported 69.87 million yuan ($10.09 Million) net loss in 2022. Zanyu Tech said the reason for its losses is due to the extreme situation of a sharp drop in raw material prices, which caused a simultaneous drop in product prices and a significant decrease in the gross profit margin of its core business, resulting in a negative impact on profits. According to its financial report, Zanyu Tech is a high-tech enterprise specializing in the research and development, production, and OEM/ODM business of surfactants, oleochemicals, and washing and care products. The company is headquartered in Hangzhou and has industrial production bases in Hangzhou and Jiaxing, Jiangsu and Jakarta, Indonesia. The annual production capacity of surfactants has exceeded 1.1 million tons, and that of oleochemicals has exceeded 1 million tons. During the reporting period, the surfactants and oleochemicals business accounted for more than 96% of the company's main business revenue and was the main component of the company's main business. In terms of business segments, in 2022, the revenue of Zanyu Tech's surfactants business segment reached 3.51 billion yuan ($ 507.7 million), an increase of 13.4% compared to the same period last year, with a sales gross profit margin of 4.33%, a decrease of 10.08 percentage points from the same period last year. The company sold 473,700 tons of surfactants in 2022, an increase of 10.5% compared to 2021. In the oleochemicals business segment, Zanyu Tech 's revenue increased by 1.04% to 7.36 billion yuan ($ 1.06 billion) with a sales gross profit margin of 5.79%, a decrease of 8.61 percentage points from the same period last year. The company sold 836,900 tons of oleochemicals in 2022, an increase of 6.45% compared to 2021. Zanyu Technology stated that in 2023, the company will focus on its main business, especially in expanding its OEM/ODM business in the washing and care industry and developing refined products such as OPO. It will also strengthen inventory position management, more accurately controlling the level of inventory based on predictions of raw material price trends and the company's business situation. The company will enhance its raw material procurement management by taking advantage of differences in the timing and magnitude of price fluctuations between domestic and foreign markets to make timely and optimal purchases. The company will also use moderate hedging to reduce the risks of fluctuations in raw material prices and minimize the impact of such fluctuations on product profitability by employing downstream customer processing models and upstream long-term supply agreements.

Dencare Oral, the parent company of the Chinese famous toothpaste Brand Lesening, posted a 343 million yuan ($49.48 million) in operating revenue in 2023 Q1, saw growth of 10.65% compared to the same period of 2022. Dencare (Chongqing) Oral Care Co., Ltd. (Dencare Oral), the parent company of the Chinese famous toothpaste Brand Lesening, posted a 343 million yuan ($49.48 million) in operating revenue in 2023 Q1, saw growth of 10.65% compared to the same period of 2022. The company’s net profit reached 32.28 million yuan ($4.66 million), a year-on-year increase of 13.54%. Dencare Oral is primarily involved in the production and sale of oral care products under its brands "Dencare", "Lesening", and "Yiyan". These products include toothpaste, toothbrushes, mouthwash, electric toothbrushes, water flossers, oral antibacterial ointments and liquids, and desensitizing agents. The "Lesening" brand holds a majority market share of around 60% in the Chinese anti-sensitive toothpaste market. In terms of financial performance, Dencare Oral has been experiencing consistent growth in revenue and net profit. In 2022, the company's revenue increased by 14.95% compared to the previous year, reaching 1.313 billion yuan ($190.94 million), while its net profit increased by 13.25% to 119 million yuan($17.31 million). Dencare Oral's revenue are mainly from its adult basic oral care products. According to the prospectus, from 2019 to the first half of 2022, the revenue of the company's adult basic oral care products was RMB 886 million ($128.74 million), RMB 947 million ($137.72 million), RMB 1.026 billion ($149.2 million), and RMB 552 million ($80.27 million), accounting for 94.12%, 92.17%, 90.00%, and 90.38% of the main business income, respectively. In terms of competition within the industry, Dencare Oral is a leading company, with higher operating income compared to other companies such as Yunnan Baiyao Group Co., Ltd, Liuzhou Liangmianzhen Co., Ltd, Perfect Group Corp., Ltd, and Lafang China Co., Ltd. According to the prospectus, Dencare Oral ranks fourth in the toothpaste market share and second among domestic brands. Additionally, its core brand "Lesening" has maintained a stable market share of around 60% in the sub-segment of anti -sensitive toothpaste through offline retail sales.